Skip to main content

Table 1 Titer assessment for HHV-6A GS strain batches expressed as TCID 50 determined by Q-PCR, ocular inspection or immunofluorescence assay (IFA), and as infectious units (Inf U) determined by IFA

From: Development and validation of a Q-PCR based TCID50 method for human herpesvirus 6

Batch

Q-PCR

Ocular inspection

Inf U/ml

IFA

HHV-6A

(passage)

TCID50/ml

TCID50/ml

 

TCID50/ml

DNA cop/ml

P17

1215 ±566 (x3)1

771 ±466 (x3)

nd2

972 ±719 (x2)

7.6e8 ±1.4e8 (x2)

P19

806 ±679 (x5)

465 ±408 (x5)

2.5e4 ±1.6e4 (x3)

649 N/A3 (x1)

16.0e8 ±1.3e8 (x2)

P21

6 ±8 (x2)

14 ±6 (x2)

nd

nd

7.7e8 ±0.15e8 (x2)

P27

7 ±6 (x3)

30 ±15 (x3)

3.9e4 N/A (x1)

13 ±3 (3x)

nd

P17 UV-inact.

0 N/A (x1)

0 N/A (x1)

nd

nd

nd

P17 heat-inact.

20 N/A (x1)

4 N/A (x1)

nd

nd

nd

  1. 1 Number of replications of titer assessments for each passage.
  2. 2 nd: Not done.
  3. 3 N/A: Not applicable.
  4. Ocular inspection was performed by two independent assessors. Data presented are means ± standard deviations.